E-LIB Suche - Ergebnisse für: Donoghue, Mark T. A.

1

Genome-wide loss of heterozygosity predicts aggressive, tre..:

Lin, Andrew L. ; Rudneva, Vasilisa A. ; Richards, Allison L....
Acta Neuropathologica. 147 (2024) 1 - p. , 2024

Link: https://doi.org/10.1007/..

2

Convergent evolution of BRCA2 reversion mutations under the..:

Walmsley, Charlotte S. ; Jonsson, Philip ; Cheng, Michael L....
npj Precision Oncology. 8 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

Therapy-Induced Senescence Contributes to the Efficacy of A..:

Gleason, Caroline E. ; Dickson, Mark A. ; Klein (Dooley), Mary E....
Clinical Cancer Research. 30 (2023) 4 - p. 703-718 , 2023

Link: https://doi.org/10.1158/..

4

Immune-related Adverse Events after Immune Checkpoint Block..:

Rosenbaum, Evan ; Seier, Kenneth ; Bradic, Martina...
Cancer Research Communications. 3 (2023) 10 - p. 2118-2125 , 2023

Link: https://doi.org/10.1158/..

5

Clinical and Molecular Features of Long-term Response to Im..:

Thummalapalli, Rohit ; Ricciuti, Biagio ; Bandlamudi, Chaitanya...
Clinical Cancer Research. 29 (2023) 21 - p. 4408-4418 , 2023

Link: https://doi.org/10.1158/..

6

Assessing the Genomic Landscape of Cervical Cancers: Clinic..:

Friedman, Claire F. ; Ravichandran, Vignesh ; Miller, Kathryn...
Clinical Cancer Research. 29 (2023) 22 - p. 4660-4668 , 2023

Link: https://doi.org/10.1158/..

7

Lineage tracing reveals clonal progenitors and long-term pe..:

Pai, Joy A. ; Hellmann, Matthew D. ; Sauter, Jennifer L....
Cancer Cell. 41 (2023) 4 - p. 776-790.e7 , 2023

Link: https://doi.org/10.1016/..

8

Genomic and transcriptomic determinants of response to neoa..:

Chatila, Walid K. ; Kim, Jin K. ; Walch, Henry...
Nature Medicine. 28 (2022) 8 - p. 1646-1655 , 2022

Link: https://doi.org/10.1038/..

9

Ordered and deterministic cancer genome evolution after p53..:

Baslan, Timour ; Morris IV, John P. ; Zhao, Zhen...
Nature. 608 (2022) 7924 - p. 795-802 , 2022

Link: https://doi.org/10.1038/..

10

Anatomic position determines oncogenic specificity in melan..:

Weiss, Joshua M. ; Hunter, Miranda V. ; Cruz, Nelly M....
Nature. 604 (2022) 7905 - p. 354-361 , 2022

Link: https://doi.org/10.1038/..

11

Reversion mutations in germline BRCA1/2-mutant tumors revea..:

Murciano-Goroff, Yonina R. ; Schram, Alison M. ; Rosen, Ezra Y....
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

12

Genomic characterization of metastatic patterns from prospe..:

Nguyen, Bastien ; Fong, Christopher ; Luthra, Anisha...
Cell. 185 (2022) 3 - p. 563-575.e11 , 2022

Link: https://doi.org/10.1016/..

13

Genomic heterogeneity as a barrier to precision oncology in..:

Clinton, Timothy N. ; Chen, Ziyu ; Wise, Hannah...
Cell Reports. 41 (2022) 12 - p. 111859 , 2022

Link: https://doi.org/10.1016/..

14

Pilot study of bempegaldesleukin in combination with nivolu..:

D'Angelo, Sandra P. ; Richards, Allison L. ; Conley, Anthony P....
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

15

AKT mutant allele-specific activation dictates pharmacologi..:

Shrestha Bhattarai, Tripti ; Shamu, Tambudzai ; Gorelick, Alexander N....
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..